Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 884 of 1,261
  1. US 8383654

    Heterocyclic antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  2. US 8383647

    Quinoline derivative

    Takeda Pharmaceutical Company Limited · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  3. US 8383669

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Theravance, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  4. US 8383633

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  5. US 8383628

    Pyridyl derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  6. US 8383858

    Processes and intermediates for preparing steric compounds

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  7. US 8383589

    Aegyptin and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  8. US 8383580

    Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  9. US 8383576

    LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  10. US 8383645

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  11. US 8383583

    Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  12. US 8378107

    Heteroaryl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  13. US 8377966

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  14. US 8377637

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  15. US 8377924

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  16. US 8378124

    Preparation of protected alpha-keto beta-amino esters and amides

    Vertex Pharmaceuticals Incorporated · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  17. US 8378121

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  18. US 8378109

    Labeled ALPHA4BETA2 ligands and methods therefor

    The Regents of the University of California · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  19. US 8377964

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  20. US 8378084

    Fusion molecule based on novel TAA variant

    The Regents of the University of California · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  21. US 8378071

    Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  22. US 8377959

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  23. US 8377965

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  24. US 8377945

    Small molecule inhibitors of spleen tyrosine kinase (SYK)

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.